Gefticip 250 mg Tablet | 10 Tablets in 1 Strip

Introduction of Gefticip 250 mg Tablet

Gefticip 250 mg Tablet is a medicine used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body in patients with abnormal EGFR genes who have not had previous cancer treatment. However, this particular drug, Gefticip 250 mg, is not suitable for use in children or adolescents because of unknown safety and effectiveness in these age groups.

Gefticip 250 mg Tablet can cause various side effects, including diarrhea, rash and nausea. It may also cause potentially serious side effects such as liver damage and lung inflammation. If you experience any side effects while taking Gefticip 250 Tablet, it is important to discuss them with your doctor. It is important to note that if you are allergic to Gefticip 250 mg or any of its ingredients, you should not use Gefticip Tablet. If you are pregnant, planning to become pregnant or breastfeeding, it is advisable to consult your doctor before using this medicine.

Before starting Gefticip 250 mg Tablet, it is important to have a conversation with your doctor about the potential risks and benefits associated with this medication. You should also discuss any other questions or concerns you may have. It is also important to tell your doctor about any medical conditions you have and any other medicines, vitamins, supplements or herbal products you are currently taking.

Uses of Gefticip 250 mg Tablet

​Non-small cell lung cancer: Gefticip 250 mg Tablet is prescribed for the treatment of non-small cell lung cancer, a form of lung cancer that impacts a significant number of cells within the lung.

Benefits of Gefticip 250 mg Tablet

Gefticip Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Gefticip 250 Tablet may help to slow the progression of cancer.

Gefticip 250 mg may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.

Gefticip 250 mg Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.

Side Effects of Gefticip 250 mg Tablet

As with all medicines, Gefticip 250 mg Tablet may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.

Most Common Side Effects of Gefticip 250 mg Tablet

• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
  

Common Side Effects of Gefticip 250 mg Tablet

• Liver Damage
• Seizures
• Infection
• Kidney Damage
• Memory Problems
• Vision Problems
• Sleeplessness
  

How to Use Gefticip 250 mg Tablet?

It is recommended to consume Gefticip 250 mg Tablet with or without food. Ensure to swallow the tablet whole with a complete glass of water. Avoid crushing, chewing, or opening the tablet. In case you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and adhere to your regular dosing schedule. Remember not to take two doses simultaneously to compensate for a missed dose.

How Gefticip 250 mg Tablet Works?

Gefticip 250 mg works by inhibiting the activity of the epidermal growth factor receptor (EGFR) protein, which is found on the surface of cells and is involved in the growth and proliferation of cancer cells. When EGFR is activated, it sends signals to the inside of the cell to grow and divide. Gefticip 250 Tablet binds to the EGFR and prevents it from activating, thereby inhibiting the growth and proliferation of cancer cells.

Safety Advices Gefticip 250 mg Tablet

Alcohol

Unsafe

Kidney

Use with Caution

Liver

Use with Caution

Driving

Unsafe

Pregnancy

Unsafe

Breastfeeding

Unsafe

References

1. Gefitinib Tablets, Natco Pharma (Canada) Inc. Mississauga, Product Leaflet 

2. Iressa 250 Mg Film-coated Tablets, AstraZeneca Ab, Product Monograph 

3. Summary Of Risk Management Plan For Gefitinib 250 Mg Film-coated Tablets, Qilu Pharma Spain S.l. Available Form 

4. Iressa (gefitinib Tablets, AstraZeneca Pharmaceuticals Lp, Uk, Product Monograph 

5. Iressa 250 Mg Film Coated Tablets, AstraZeneca Limited, Product Leaflet 

6. Gefitinib 250 Mg Film-coated Tablet, Available Form